Literature DB >> 25337756

Breast-cancer risk in families with mutations in PALB2.

Antonis C Antoniou, William D Foulkes, Marc Tischkowitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25337756     DOI： 10.1056/NEJMc1410673

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

Review 1.  The current state of molecular testing in the treatment of patients with solid tumors, 2019.

Authors:  Wafik S El-Deiry; Richard M Goldberg; Heinz-Josef Lenz; Anthony F Shields; Geoffrey T Gibney; Antoinette R Tan; Jubilee Brown; Burton Eisenberg; Elisabeth I Heath; Surasak Phuphanich; Edward Kim; Andrew J Brenner; John L Marshall
Journal:  CA Cancer J Clin       Date:  2019-05-22       Impact factor: 508.702

2.  Two Steps Forward and One Step Back for Precision in Prostate Cancer Treatment.

Authors:  Michael T Schweizer; Heather H Cheng; Peter S Nelson; R Bruce Montgomery
Journal:  J Clin Oncol       Date:  2020-09-08       Impact factor: 44.544

Review 3.  Genomic Biomarkers for Breast Cancer Risk.

Authors:  Michael F Walsh; Katherine L Nathanson; Fergus J Couch; Kenneth Offit
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 4.  Is metastatic pancreatic cancer an untargetable malignancy?

Authors:  Hampig Raphael Kourie; Joseph Gharios; Fadi Elkarak; Joelle Antoun; Marwan Ghosn
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

5.  Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families.

Authors:  Mev Dominguez-Valentin; Sigve Nakken; Hélène Tubeuf; Daniel Vodak; Per Olaf Ekstrøm; Anke M Nissen; Monika Morak; Elke Holinski-Feder; Alexandra Martins; Pål Møller; Eivind Hovig
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

6.  Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer.

Authors:  Ruta Sahasrabudhe; Paul Lott; Mabel Bohorquez; Ted Toal; Ana P Estrada; John J Suarez; Alejandro Brea-Fernández; José Cameselle-Teijeiro; Carla Pinto; Irma Ramos; Alejandra Mantilla; Rodrigo Prieto; Alejandro Corvalan; Enrique Norero; Carolina Alvarez; Teresa Tapia; Pilar Carvallo; Luz M Gonzalez; Alicia Cock-Rada; Angela Solano; Florencia Neffa; Adriana Della Valle; Chris Yau; Gabriela Soares; Alexander Borowsky; Nan Hu; Li-Ji He; Xiao-You Han; Philip R Taylor; Alisa M Goldstein; Javier Torres; Magdalena Echeverry; Clara Ruiz-Ponte; Manuel R Teixeira; Luis G Carvajal-Carmona
Journal:  Gastroenterology       Date:  2016-12-23       Impact factor: 22.682

7.  Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.

Authors:  Jun Li; Huong Meeks; Bing-Jian Feng; Sue Healey; Heather Thorne; Igor Makunin; Jonathan Ellis; Ian Campbell; Melissa Southey; Gillian Mitchell; David Clouston; Judy Kirk; David Goldgar; Georgia Chenevix-Trench
Journal:  J Med Genet       Date:  2015-11-03       Impact factor: 6.318

8.  Inherited DNA-Repair Defects in Colorectal Cancer.

Authors:  Saud H AlDubayan; Marios Giannakis; Nathanael D Moore; G Celine Han; Brendan Reardon; Tsuyoshi Hamada; Xinmeng Jasmine Mu; Reiko Nishihara; Zhirong Qian; Li Liu; Matthew B Yurgelun; Sapna Syngal; Levi A Garraway; Shuji Ogino; Charles S Fuchs; Eliezer M Van Allen
Journal:  Am J Hum Genet       Date:  2018-02-22       Impact factor: 11.025

9.  The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response.

Authors:  Yue Zhang; Jung-Young Park; Fan Zhang; Sara H Olson; Irene Orlow; Yirong Li; Robert C Kurtz; Marc Ladanyi; Jie Chen; Amanda E Toland; Liying Zhang; Paul R Andreassen
Journal:  Hum Mutat       Date:  2020-12-16       Impact factor: 4.878

10.  Implications of the germline variants of DNA damage response genes detected by cancer precision medicine for radiological risk communication and cancer therapy decisions.

Authors:  Noriko Hosoya; Kiyoshi Miyagawa
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.